Home
 
Home
Stock Research
Fund Research
Markets
Forex
Options
Retirement
Real Estate
News
Commentary
University
Featured Content
Free Newsletters
Financial Glossary
Business Glossary
The market in:
: :
ESRX Overview
ESRX Charts
ESRX News
ESRX Profile
ESRX Analysis
ESRX Offers

InvestorGuide Stock Analysis

Express Scripts buys WellPoint's NextRx
Excerpt from the InvestorGuide.com Stock of the Day on 4/13/2009

In a sea of shake-ups, downsizes, and bankruptcies, some companies are choosing to acquire other businesses to either prevent the destruction of one company or create a company that is able to withstand the harsh conditions that a downturn in the economy inflicts on some companies. Express Scripts announced on Monday that is has decided to acquire a subsidiary of WellPoint Inc. in a deal valued at $4.7 billion. This amount will be paid in cash and up to $1.4 billion in common stock. What were a couple of the reasons behind the company's decision to acquire a subsidiary of WellPoint Inc.? Will the deal be beneficial for the both parties involved? How will this deal change the structure of Express Scripts?

Acquisition and merger announcements have become a common occurrence over the last year as companies try their best to cope with the global economic recession. Some companies choose to acquire an entire company and some companies choose to acquire certain parts. Express Scripts has chosen to do the latter. WellPoint Inc. currently owns and operates Next RX, which is a premier provider of pharmacy benefit management services nationally. Next RX was founded in 1993 and currently manages more than 265 million adjusted prescriptions annually. One of the main reasons for the acquisition is to expand the company's presence in a market that it has always wanted to expand in. By expanding, pharmacy benefit managers, such as Express Scripts, would gain clout when negotiating prices with drug makers for clients, typically big corporations and their employees. The acquisition will result in more than 32 million additional customers being added to Express Scripts, which will result in the company providing prescription services to almost 82 million individuals. More >

Subscribe to the Stock of the Day!
 

Add to tracker
What is Morningstar's rating for Express Scripts?

InvestorGuide Stock of the Day RSS feed

RSS
Express Scripts, Inc. Makes Unsolicited Bid for Caremark
Excerpt from the InvestorGuide.com Stock of the Day on 12/18/2006

Tremors are still being felt after Express Scripts Inc. made an announcement this morning that has shaken the health care industry and left competing companies bewildered. In an unsolicited takeover bid for Caremark RX (CMX: Charts, News, Offers), Express Scripts has trumped the deal struck just last month between Caremark and CVS (CVS: Charts, News, Offers) by about $4bn. The health care industry is still reeling from Wal-Mart's announcement that they will be offering low-priced, generic prescriptions as this news kicks off another round of uncertainty. Should Caremark consider accepting Express Scripts' bid? What are the implications to the industry if it goes through? More >

Trading Offers

•
Buy Express Scripts for just $4

Special Offers

•
Learn to spot opportunities in any market with a Risk-Free* 30-day trial from Investools.

Morningstar Analysis for Express Scripts

Express Scripts (ESRX) Upgrades

Date
Analyst
Old Rating
New Rating
04/21/2009
SunTrust
Neutral
Buy
04/14/2009
UBS
Neutral
Buy
03/13/2009
Argus
Hold
Buy
10/30/2007
Morgan Stanley
Equal Weight
Overweight
07/30/2007
Matrix Research
Hold
Buy
03/20/2007
UBS
Buy
Neutral

Express Scripts (ESRX) Downgrades

Date
Analyst
Old Rating
New Rating
06/19/2008
UBS
Buy
Neutral
01/14/2008
JP Morgan
Overweight
Neutral
01/09/2008
Wachovia
Outperform
Mkt Perform
10/09/2006
UBS
Neutral
Buy
04/10/2006
Morgan Stanley
Underweight
Equal-Weight
09/22/2005
Goldman Sachs
Underperform
N/A

Express Scripts (ESRX) New Coverage

Date
Analyst
Rating
11/19/2009
Stifel Nicolaus
Hold
Buy Express Scripts for just $4

Special Offers

Buy Express Scripts for just $4
www.sharebuilder.com
What is Morningstar's rating for Express Scripts?
www.morningstar.com

Learn to spot opportunities in any market with a Risk-Free* 30-day trial from Investools.
www.investools.com
Lightspeed Trading. Get the unfair advantage of a platform built for traders, by traders.
www.lightspeed.com
Download a free Options Fundamentals Podcast, from The Options Industry Council.
OptionsEducation.org

ESRX Links

Guru Analysis:
MSN Money | Morningstar | Stock Consultant

Analyst Opinions:
Reuters | SmartMoney | MarketWatch | Nasdaq | BarChart | Schaeffers | CNN Money | TheStreet

Blogs:
SocialPicks | Topix.net | SeekingAlpha | Technorati | Ask.com

Message Boards:
ClearStation | RagingBull | Yahoo | Investopedia | FreeRealTime | StockHouse Trading Offers:
Buy ESRX for just $4

Competitor Analysis

MedcoHealth Solutions
TLC Vision
Omnicare
American Dental Partners
Get Analysis For: